The supporting evidence will need to be gathered over a number of years, so while I have some skin in this game- they should have had something already running with strong supporters of the product ie hospital department who have core expertise so peer reviewed articles can be published. Hopefully GE can give some traction.
OSP Price at posting:
1.4¢ Sentiment: Hold Disclosure: Held
